Art and Science of Laboratory Medicine

Art and Science of Laboratory Medicine

Thursday, March 5, 2015

First Lipoprotein(a) Particle Concentration Assay

Researchers at Health Diagnostic Laboratory Inc. (HDL Inc.) have developed a novel, proprietary method to measure atherogenic lipoprotein(a) particle concentration [Lp(a)-P]. The new method relies on modern immuno-electrophoretic techniques that separate and identify particles based on their charge and size, as opposed to current assays that measure either the amount of cholesterol contained in the Lp(a) fraction or, more commonly, the total mass of the Lp(a) particles in the circulation.

"With this breakthrough in Lp(a) analytical methodology, we are finally able to assess Lp(a) particle concentrations - which we think can be more powerful than Lp(a) mass or cholesterol - as predictors of cardiovascular risk," said Joseph McConnell, PhD, senior author of the paper and president and CEO of HDL Inc.

Read more:
Health Diagnostic Laboratory Announces First Lipoprotein(a) Particle Concentration Assay

Source: ADVANCE


No comments:

Follow "Art and Science of Laboratory Medicine " on:


https://www.facebook.com/LaboratoryEQAS
https://twitter.com/LaboratoryEQAS
https://plus.google.com/100408138227362094524/posts
http://www.pinterest.com/labmed/medical-laboratory-and-biomedical-science/
http://www.linkedin.com/in/jwahlstedt
http://clinical-laboratory.blogspot.com/feeds/posts/default